Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)
Clinical trial NCT01117987 · TERMINATED
Trial details
- NCT number
- NCT01117987
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2014-04-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.